HealthPhoto: The ASCO PostImmunotherapy Downstaging Improves Liver Transplant Outcomes in Liver Cancer
A multicenter matched cohort study in China found that immune checkpoint inhibitor–based downstaging in hepatocellular carcinoma patients led to better post-liver transplant survival and reduced recurrence risk. This approach shows promise in improving outcomes for liver cancer patients undergoing transplantation by enhancing tumor response before surgery.
The ASCO Post·


